Rifaximin Versus Lactulose in Renal Failure
Rifaximin Versus Lactulose in Renal Failure
The purpose of this study is to evaluate patients with cirrhosis of the liver and renal
 failure and determine if the administration of rifaximin as compared to lactulose is
 associated with less frequent and/or slower progression to severe hepatic encephalopathy. If
 one is associated with lower blood ammonia levels. And, if one is associated with lower
 breath hydrogen and methane levels.
Inclusion Criteria:

 -  cirrhosis of liver of any etiology

 -  progressive renal failure

 -  stage 0-2 hepatic encephalopathy

 Exclusion Criteria:

 -  pregnant women